The Effects of Single Baduanjin and Elastic Band Exercises on VSWM in Elderly Individuals With MCI

June 14, 2026 updated by: qiu chen

The Effects of Single Baduanjin and Elastic Band Exercises on Visuospatial Working Memory in Elderly Individuals With Mild Cognitive Impairment

Previous studies have confirmed that both acute (single) and long-term various exercise interventions can significantly improve the cognitive function of individuals with MCI. The positive effects of long-term Qigong and elastic band exercises have also been verified. There are relatively few studies on the impact of Qigong and elastic band exercises on working memory. Most studies focusing on working memory mainly target children and college students. The effect of these exercises on the elderly has not been proven, and the improvement mechanism has not been clarified either. This article mainly starts from a single exercise perspective to explore whether a single exercise can improve the VSWM of elderly individuals with MCI. From the perspective of neurophysiology, it also discusses the brain mechanism of single Qigong and elastic band exercises on the working memory of cognitively impaired elderly people, providing reference for future long-term exercise prescriptions for the treatment and prevention of Alzheimer's disease in China.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- Include the elderly population aged between 60 and 74 years old.

- Includes individuals with cognitive impairments. The patients or informants report experiencing memory decline and having certain cognitive dysfunction (MoCA score = 18-25 points).

- Including individuals who have controlled diabetes and/or cardiovascular diseases to a stable state.

- Irregular exercise with the ability to complete a certain amount of physical activities.

- Normal vision and hearing.

Exclusion Criteria:

- Patients with moderate to severe cognitive impairment, mental illness or other neurodegenerative diseases (such as Parkinson's dementia, stroke, frontotemporal degeneration, vascular dementia, Lewy body dementia, etc.).

- Long-term or recent use of psychotropic drugs, drugs that affect physical activity ability, cholinergic inhibitors, etc.

- Regular exercise habit .

- There are serious muscle disorders, or there has been an injury to the lower limbs within the previous six months, making it impossible to stand for a long time or to stand at all.

- Severe cardiovascular disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Experimental: baduanjin
Perform the 30-minute Baduanjin exercise
Experimental: Resistance band
Perform 30 minutes of elastic band exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visuo-spatial working memory
Time Frame: From July 1, 2026, to September 1, 2026, the duration is two months.
The primary research outcome pertains to visuospatial working memory, which is measured through a visuospatial working memory task paradigm. The specific paradigm is as follows: First, a "+" appears in the middle of a gray computer screen for 300 ms. Second, a 4x4 grid matrix appears at the center of the screen for 2000 ms, with 5 small black squares randomly placed within the matrix. Immediately afterwards, a blank screen is presented for 3000 ms. During this period, the participants are required to mentally visualize the probe stimulus after rotating it 90° to the left (or right). Subsequently, a 4x4 grid target stimulus is presented again for 4000 ms, and the participants need to make a judgment on the target stimulus, specifically whether it is the result of rotating the probe stimulus 90° to the left (or right), as shown in Figure 3. The entire experiment lasts approximately 8 minutes.
From July 1, 2026, to September 1, 2026, the duration is two months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EEG power value
Time Frame: The total duration was two months.
The testers adjusted the impedance to below 5kΩ and followed the 26-system electrode placement method specified by the International Federation of Electroencephalography. They set Fp1, Fp2, F3, F4, F7, F8, Fc3, Fc4, C3, C4, Cp3, Cp4, P3, P4, Pz, O1, O2, Oz, Po3, Po4, T3, T4, T5, and T6 leads. The ground electrode was set as GND, and the reference electrode was at the bilateral earlobe positions of A1 and A2. After stabilization, they began to record the EEG signals for 5 minutes. Using the toolbox, they filtered out data segments with obvious artifact interference. They analyzed the EEG indicators, including frontal cortex δ-β2 (Fp1, Fp2, F3, F4, F7, F8, AF3, AF4, Fc3, Fc4), central cortex δ-β2 (C3, C4, Cp3, Cp4), parietal cortex δ-β2 (P3, P4, Pz), occipital cortex δ-β2 (O1, O2, Oz, Po3, Po4), and temporal cortex δ-β2 (T3, T4, T5, T6).
The total duration was two months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 14, 2026

Study Registration Dates

First Submitted

May 27, 2026

First Submitted That Met QC Criteria

June 14, 2026

First Posted (Actual)

June 18, 2026

Study Record Updates

Last Update Posted (Actual)

June 18, 2026

Last Update Submitted That Met QC Criteria

June 14, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 183551747

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment (MCI)

Clinical Trials on baduanjin exercise

Subscribe